Dr. Sheila Weinmann is a member of the KPRB Leadership Team and the KP Research Bank Scientific Lead representing Kaiser Permanente Northwest (serving NW Oregon and SW Washington). She is an epidemiologist whose research focuses on cancer etiology, screening, and progression, with particular emphasis on molecular epidemiology. Her interests also include pharmacoepidemiology and infectious disease epidemiology.
Dr. Weinmann has more than 25 years’ experience leading epidemiologic studies at the Kaiser Permanente Center for Health Research in Portland, Oregon and at the University of Washington. Presently, she is leading a study of molecular factors in relation to breast cancer recurrence and well as studies of statin use in relation to breast and prostate cancer recurrence. She has also led epidemiologic studies on efficacy of screening for prostate cancer, cervical cancer, and colorectal cancer; molecular and other factors in relation to prostate cancer mortality after prostatectomy; renal cell cancer risk factors and the molecular biology of renal cell cancer progression; and pregnancy outcomes after surgical treatment for cervical dysplasia. In addition, Dr. Weinmann has conducted research on bladder cancer, childhood cancers, varicella, herpes zoster, human papillomavirus (HPV), invasive pneumococcal disease, pertussis, chronic obstructive pulmonary disease, and primary cardiac arrest.
Dr. Weinmann received her PhD in epidemiology from the University of Washington and her Masters of Public Health degree from the University of Texas. Her undergraduate degree is from Rice University. She is a Clinical Assistant Professor in the Department of Public Health and Preventive Medicine of Oregon Health & Science University. She is a former Executive Director of the Northwest Portland Area Indian Health Board and has worked on several studies of health problems among American Indians and Alaska Natives.